Microparticles variability in fresh frozen plasma: Preparation protocol and storage time effects

Blood Transfusion

Volumn 14, Issue 3, 2016, Pages 228-237

  Kriebardis, Anastasios G ^a   Antonelou, Marianna H ^b   Georgatzakou, Hara T ^b   Tzounakas, Vassilis L ^b   Stamoulis, Konstantinos E ^c   Papassideri, Issidora S ^b  

^a TEI of Athens   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Hellenic National Diabetic Centre   (Greece)

Author keywords

Extracellular Vesicles; Fresh Frozen Plasma; Microparticles; Prothrombotic Activity.; Storage

Indexed keywords

FRESH FROZEN PLASMA; PROCOAGULANT;

ADULT; ARTICLE; BLOOD DONOR; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROCYTE MICROPARTICLE; ERYTHROCYTE PRESERVATION; FLOW CYTOMETRY; FREEZE THAWING; HUMAN; IN VIVO STUDY; LEUKOCYTE MICROPARTICLE; MALE; MEAN CORPUSCULAR VOLUME; MEMBRANE MICROPARTICLE; PLATELET MICROPARTICLE; THROMBOCYTE PRESERVATION; THROMBOCYTE RICH PLASMA; THROMBOCYTE VOLUME; BLOOD STORAGE; HEMOSTASIS; PLASMA; THROMBOCYTE;

BLOOD PLATELETS; BLOOD PRESERVATION; CELL-DERIVED MICROPARTICLES; FLOW CYTOMETRY; HEMOSTASIS; HUMANS; PLASMA; PLATELET-RICH PLASMA;

EID: 84977111917     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2016.0179-15     Document Type: Article

References (62)

1. Aatonen M, Gronholm M, Siljander PR. Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin Thromb Hemost 2012; 38: 102-13.
2. Gyorgy B, Szabo TG, Pasztoi M et al. Membrane vesicles, current state-of-The-Art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011; 68: 2667-88.
3. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-93.
4. Bastos-Amador P, Royo F, Gonzalez E et al. Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability. J Proteomics 2012; 75: 3574-84.
5. Shai E, Rosa I, Parguina AF, et al. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics 2012; 76: 287-96.
6. Larson MC, Hillery CA, Hogg N. Circulating membrane-derived microvesicles in redox biology. Free Radic Biol Med 2014; 73: 214-28.
7. Baron M, Boulanger CM, Staels B, Tailleux A. Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? J Cell Mol Med 2012; 16: 1365-76.
8. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-71.
9. Kriebardis A, Antonelou M, Stamoulis K, et al. Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-Transfusion reactions? Blood Transfus 2012; 10 (Suppl 2) : s25-38.
10. Antonelou MH, Kriebardis AG, Stamoulis KE, et al. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-Adenine-glucose-mannitol. Transfusion 2010; 50: 376-89.
11. Maslanka K, Uhrynowska M, Lopacz P, et al. Analysis of leucocyte antibodies, cytokines, lysophospholipids and cell microparticles in blood components implicated in post-Transfusion reactions with dyspnoea. Vox Sang 2015; 108: 27-36.
12. Peters AL, van Hezel ME, Juffermans NP, et al. Pathogenesis of non-Antibody mediated transfusion-related acute lung injury from bench to bedside. Blood Rev 2015; 29: 51-61.
13. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
14. Lawrie AS, Harrison P, Cardigan RA, et al. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. Vox Sang 2008; 95: 197-204.
15. Lawrie AS, Cardigan RA, Williamson LM, et al. The dynamics of clot formation in fresh-frozen plasma. Vox Sang 2008; 94: 306-14.
16. Ayers L, Kohler M, Harrison P, et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 2011; 127: 370-7.
17. Roback JD, Grossman BJ, Harris T, et al. AABB Technical Manual. 17th ed. Bethesda, MD: AABB; 2011.
18. Matijevic N, Wang YW, Kostousov V, et al. Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma. Thromb Res 2011; 128: 35-41.
19. Connor DE, Exner T, Ma DD, et al. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010; 103: 1044-52.
20. Lacroix R, Robert S, Poncelet P, et al. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010; 8: 2571-4.
21. Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999; 299: 15-27.
22. Duplancic D, Kukoc-Modun L, Modun D, et al. Simple and rapid method for the determination of uric acid-independent antioxidant capacity. Molecules 2011; 16: 7058-68.
23. van Beers EJ, Schaap MC, Berckmans RJ, et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009; 94: 1513-9.
24. Sparrow RL, Chan KS. Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: pre-Analytical considerations for proteomic investigations. J Proteomics 2012; 76 Spec No.:211-9.
25. Bosman GJ, Werre JM, Willekens FL, et al. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008; 18: 335-47.
26. Rizvi SI, Maurya PK. Markers of oxidative stress in erythrocytes during aging in humans. Ann N Y Acad Sci 2007; 1100: 373-82.
27. Michelsen AE, Noto AT, Brodin E, et al. Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state. Thromb Res 2009; 123: 881-6.
28. Marcus AJ, Safier LB, Hajjar KA, et al. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest 1991; 88: 1690-6.
29. Krailadsiri P, Seghatchian J, Macgregor I, et al. The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components. Transfusion 2006; 46: 407-17.
30. Jy W, Horstman LL, Jimenez JJ, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-51.
31. Shah MD, Bergeron AL, Dong JF, et al. Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 2008; 19: 365-72.
32. George JN, Pickett EB, Heinz R. Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates. Transfusion 1988; 28: 123-6.
33. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20: 1-26.
34. George JN, Pickett EB, Heinz R. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 1986; 68: 307-9.
35. Egidi MG, D'Alessandro A, Mandarello G, et al. Troubleshooting in platelet storage temperature and new perspectives through proteomics. Blood Transfus 2010; 8 (Suppl 3) : s73-81.
36. Bode AP, Knupp CL. Effect of cold storage on platelet glycoprotein Ib and vesiculation. Transfusion 1994; 34: 690-6.
37. Correia JJ, Williams RC Jr. Mechanisms of assembly and disassembly of microtubules. Annu Rev Biophys Bioeng 1983; 12: 211-35.
38. Mobarrez F, Antovic J, Egberg N, et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 2010; 125: e110-6.
39. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010; 107: 1047-57.
40. Fourcade O, Simon MF, Viode C, et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 1995; 80: 919-27.
41. Matijevic N, Kostousov V, Wang YW, et al. Multiple levels of degradation diminish hemostatic potential of thawed plasma. J Trauma 2011; 70: 71-9; discussion 79-80.
42. Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50-To 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425-34.
43. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-49.
44. Sims PJ, Wiedmer T, Esmon CT, et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-57.
45. Cauwenberghs S, Feijge MA, Harper AG, et al. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett 2006; 580: 5313-20.
46. McGill M, Fugman DA, Vittorio N, et al. Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits. J Lab Clin Med 1987; 109: 127-33.
47. Hrachovinova I, Cambien B, Hafezi-Moghadam A, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003; 9: 1020-5.
48. Horne MK 3rd, Cullinane AM, Merryman PK, et al. The effect of red blood cells on thrombin generation. Br J Haematol 2006; 133: 403-8.
49. Rubin O, Delobel J, Prudent M, et al. Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation. Transfusion 2013; 53: 1744-54.
50. Jy W, Johansen ME, Bidot C Jr, et al. Red cell-derived microparticles (RMP) as haemostatic agent. Thromb Haemost 2013; 110: 751-60.
51. Bosman GJ, Lasonder E, Luten M, et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008; 48: 827-35.
52. Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. Circ Res 2012; 110: 356-69.
53. Johnson L, Coorey CP, Marks DC. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion 2014; 54: 1917-26.
54. Macey MG, Enniks N, Bevan S. Flow cytometric analysis of microparticle phenotype and their role in thrombin generation. Cytometry B Clin Cytom 2011; 80: 57-63.
55. Trappenburg MC, van Schilfgaarde M, Marchetti M, et al. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica 2009; 94: 911-8.
56. Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108: 1284-97.
57. Del Conde I, Shrimpton CN, Thiagarajan P, et al. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604-11.
58. Key NS. Analysis of tissue factor positive microparticles. Thromb Res 2010; 125 (Suppl 1) : S42-5.
59. Livnat T, Zivelin A, Martinowitz U, et al. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI. J Thromb Haemost 2006; 4: 192-200.
60. Helal O, Defoort C, Robert S, et al. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. Nutr Metab Cardiovasc Dis 2011; 21: 665-71.
61. Buttari B, Profumo E, Rigano R. Crosstalk between red blood cells and the immune system and its impact on atherosclerosis. Biomed Res Int 2015; 2015: 616834.
62. Yang L, Stanworth S, Hopewell S, et al. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 2012; 52: 1673-86; quiz 1673.